Phase I/II study to evaluate the safety and clinical efficacy of atezolizumab (atezo; aPDL1) in combination with temozolomide (TMZ) and radiation in patients with newly diagnosed glioblastoma (GBM).

被引：1
|
作者：
Weathers, Shiao-Pei S.
Kamiya-Matsuoka, Carlos
Harrison, Rebecca A.
Liu, Diane D.
Dervin, Shannon
Yun, Cindy
Loghin, Monica Elena
Penas-Prado, Marta
Majd, Nazanin
Yung, W. K. Alfred
O'Brien, Barbara Jane
De Groot, John Frederick
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Genentech Inc, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2511
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Rauf, Yasmeen
    Peereboom, David
    Fallah, Jaleh
    Schilero, Cathy
    Lackner, Pamela
    Stevens, Glen
    Ahluwalia, Manmeet
    NEURO-ONCOLOGY, 2020, 22 : 37 - 37
  • [22] PHASE I STUDY OF AZD1775 WITH RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) AND EVALUATION OF INTRATUMORAL DRUG DISTRIBUTION (IDD) IN PATIENTS WITH RECURRENT GBM
    Alexander, Brian
    Supko, Jeffrey
    Agar, Nathalie
    Ahluwalia, Manmeet
    Desai, Arati
    Dietrich, Jorg
    Kaley, Thomas
    Peereboom, David
    Takebe, Naoko
    Desideri, Serena
    Fisher, Joy
    Sims, Megan
    Ye, Xiaobu
    Ligon, Keith
    Nabors, L. Burt
    Grossman, Stuart
    Wen, Patrick
    NEURO-ONCOLOGY, 2018, 20 : 13 - 14
  • [23] PAMIPARIB IN COMBINATION WITH RADIATION THERAPY (RT) AND/OR TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED OR RECURRENT/REFRACTORY (R/R) GLIOBLASTOMA (GBM); PHASE 1B/2 STUDY UPDATE
    Piotrowski, Anna
    Puduvalli, Vinay
    Wen, Patrick
    Campian, Jian
    Colman, Howard
    Pearlman, Michael
    Butowski, Nicholas
    Battiste, James
    Glass, Jon
    Cloughesy, Timothy
    Schiff, David
    van den Bent, Martin
    Walbert, Tobias
    Ahluwalia, Manmeet
    Badruddoja, Michael
    Kalra, Amandeep
    Aregawi, Dawit
    Weller, Michael
    Ramakrishnan, Vanitha
    Zhang, Kathy
    Wood, Katie
    Mellinghoff, Ingo
    Shih, Kent
    NEURO-ONCOLOGY, 2019, 21 : 21 - 22
  • [24] Phase I/II study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme (GBM) or gliosarcoma
    Butowski, N. A.
    Lamborn, K.
    Chang, S.
    Thornton, D.
    DeBoer, R.
    Page, M.
    Rabbitt, J.
    Parvanateni, R.
    Kivett, V.
    Nicol, S.
    Prados, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] Phase I study of AZD1775 with radiation therapy (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM) and evaluation of intratumoral drug distribution (IDD) in patients with recurrent GBM.
    Alexander, Brian Michael
    Ahluwalia, Manmeet Singh
    Desai, Arati Suvas
    Dietrich, Jorg
    Kaley, Thomas Joseph
    Peereboom, David M.
    Takebe, Naoko
    Supko, Jeffrey G.
    Desideri, Serena
    Fisher, Joy D.
    Sims, Megan
    Ye, Xiaobu
    Nabors, Louis B.
    Grossman, Stuart A.
    Wen, Patrick Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [26] A PHASE I STUDY OF SORAFENIB WITH RADIATION AND TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA
    Colman, Howard
    Gilbert, Mark
    Yung, W. K. Alfred
    Aldape, Ken
    De Groot, John
    Conrad, Charles
    Levin, Victor
    Groves, Morris
    Loghin, Monica
    Chris, Pelloski
    Puduvalli, Vinay
    NEURO-ONCOLOGY, 2011, 13 : 61 - 61
  • [27] PHASE 1B/2 STUDY TO ASSESS THE CLINICAL EFFECTS OF PAMIPARIB (BGB-290) IN COMBINATION WITH RADIATION THERAPY (RT) AND/OR TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED OR RECURRENT/REFRACTORY GLIOBLASTOMA (GBM)
    Shih, Kent
    Schiff, David
    Kim, Lyndon
    Battiste, James
    Campian, Jian
    Puduvalli, Vinay
    Wen, Patrick
    Cloughesy, Timothy
    van den Bent, Martin
    Pirzkall, Andrea
    Wood, Katie
    Wei, Rachel
    Du, Bing
    Mu, Song
    Ramakrishnan, Vanitha
    Walbert, Tobias
    NEURO-ONCOLOGY, 2018, 20 : 17 - 18
  • [28] GEINO 1402: A phase Ib dose-escalation study followed by an extension phase to evaluate safety and efficacy of crizotinib in combination with temozolomide (TMZ) and radiotherapy (RT) in patients with newly diagnosed glioblastoma (GB)
    Martinez Garcia, M.
    Gil, M. J.
    Pineda, E.
    Martin Soberon, M. C.
    Mesia Barroso, C.
    Foro, P.
    Capellades, J.
    Sarmiento, B.
    Bruna, J.
    Verger, E.
    Taus Garcia, A.
    Alameda, F.
    Hernandez Lain, A.
    Velasco, G.
    Sepulveda Sanchez, J. M.
    ANNALS OF ONCOLOGY, 2019, 30 : 147 - 147
  • [29] PHASE 1 STUDY EVALUATING ABT-414 WITH CONCURRENT RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Gan, H. K.
    Fichtel, L.
    Lassman, A.
    Merrell, R.
    van den Bent, M. J.
    Kumthekar, P.
    Scott, A.
    Pedersen, M.
    Gomez, E.
    Fischer, J.
    Ames, W.
    Xiong, H.
    Dudley, M.
    Roberts-Rapp, L.
    Ansell, P. J.
    Holen, K.
    Reardon, D. A.
    ANNALS OF ONCOLOGY, 2014, 25
  • [30] Phase II study to evaluate the clinical efficacy and safety of MEDI4736 in patients with glioblastoma (GBM).
    Reardon, David A.
    Dietrich, Jorg
    Kaley, Thomas Joseph
    Gan, Hui Kong
    Dunn, Gavin P.
    Cloughesy, Timothy Francis
    Lim, Michael
    Clarke, Jennifer Leigh
    Park, Andrew J.
    Pan, Linda S.
    Lai, Dominic W.
    Karakunnel, Joyson Joseph
    Robbins, Paul B.
    Narwal, Rajesh
    Venhaus, Ralph Rudolph
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345